Drug Shortage Report for TEVA-SALBUTAMOL HFA
| Report ID | 257586 |
| Drug Identification Number | 02326450 |
| Brand name | TEVA-SALBUTAMOL HFA |
| Common or Proper name | Salbutamol HFA |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | SALBUTAMOL |
| Strength(s) | 100MCG |
| Dosage form(s) | METERED-DOSE AEROSOL |
| Route of administration | INHALATION INHALATION |
| Packaging size | 1 |
| ATC code | R03AC |
| ATC description | ADRENERGICS, INHALANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2025-11-01 |
| Actual start date | 2024-03-03 |
| Estimated end date | Unknown |
| Actual end date | 2027-02-16 |
| Shortage status | Actual shortage |
| Updated date | 2025-11-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-11-12 | French | Compare |
| v5 | 2025-11-12 | English | Compare |
| v4 | 2025-11-10 | French | Compare |
| v3 | 2025-11-10 | English | Compare |
| v2 | 2025-10-22 | French | Compare |
| v1 | 2025-10-22 | English | Compare |
Showing 1 to 6 of 6